News Detail

New Delhi, 17 Jan 2023: The Centre is unlikely to procure Bharat Biotech's intranasal vaccine due to the low demand of precaution doses and receding Covid-19 cases, said people aware of the matter.
"The government may not procure it. The vaccine will, however, be avail......
View Details
Source : Economic Times
bharat biotech
incovacc
cowin
covid 19
central drugs standard control organisation
Related News
- Sriganganagar: Massive crackdown on drug traders, 14032 pills and capsules seized (23-09-2023)
- Action against three traders in Jamnagar city for selling duplicate beauty products (23-09-2023)
- Hoshiarpur: Action against person running medical store without license, 35 types of banned medicines seized (23-09-2023)
- Pharma exports grow 4.53% in August, imports grow 20% (23-09-2023)
- Fujifilm India installs 125 AMULET Innovality digital mammography machines across India (23-09-2023)
- Abbott India warns of laxatives shortage in tussle with Goa regulator (23-09-2023)
- J&K: 'Fake doctor' enters LD hospital's labour room, Govt appoints inquiry officer (22-09-2023)
- In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)